
Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.
Publication
, Journal Article
Sun, AY
Published in: JACC Clin Electrophysiol
April 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JACC Clin Electrophysiol
DOI
EISSN
2405-5018
Publication Date
April 2019
Volume
5
Issue
4
Start / End Page
513 / 515
Location
United States
Related Subject Headings
- Procainamide
- NAV1.5 Voltage-Gated Sodium Channel
- Humans
- Brugada Syndrome
- Anti-Arrhythmia Agents
- Ajmaline
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sun, A. Y. (2019). Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. JACC Clin Electrophysiol, 5(4), 513–515. https://doi.org/10.1016/j.jacep.2019.03.003
Sun, Albert Y. “Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.” JACC Clin Electrophysiol 5, no. 4 (April 2019): 513–15. https://doi.org/10.1016/j.jacep.2019.03.003.
Sun AY. Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. JACC Clin Electrophysiol. 2019 Apr;5(4):513–5.
Sun, Albert Y. “Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.” JACC Clin Electrophysiol, vol. 5, no. 4, Apr. 2019, pp. 513–15. Pubmed, doi:10.1016/j.jacep.2019.03.003.
Sun AY. Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance. JACC Clin Electrophysiol. 2019 Apr;5(4):513–515.

Published In
JACC Clin Electrophysiol
DOI
EISSN
2405-5018
Publication Date
April 2019
Volume
5
Issue
4
Start / End Page
513 / 515
Location
United States
Related Subject Headings
- Procainamide
- NAV1.5 Voltage-Gated Sodium Channel
- Humans
- Brugada Syndrome
- Anti-Arrhythmia Agents
- Ajmaline
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology